Statera Biopharma Inc
Biotechnology
Healthcare
STAB
17.69M shares
NASDAQ US
traded
03 Feb 2022
open
1.32
52 week high
5.83
high
1.40
52 week low
1.34
low
1.30
growth
-76.74%
previous Close
1.40
P/E ratio
-3
market cap
107M
div yield
0
usd
Sep 2021
qoq
revenue
237K
net incoming
-12.73M
eps
-0.47
-1,004.46 %
eps surprise
0.00 %
net profit margin
-5383.61 %
-5383.00 %
operating incoming
-9.64M
net change in cash
12.27M
cash on hand
9.22M
cost of revenue
116K
top top